TCI Wealth Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-88
Closed -$4.8K 2372
2023
Q1
$4.8K Hold
88
﹤0.01% 1563
2022
Q4
$5.5K Hold
88
﹤0.01% 1461
2022
Q3
$6K Hold
88
﹤0.01% 1398
2022
Q2
$5K Sell
88
-148
-63% -$8.11K ﹤0.01% 1558
2022
Q1
$15K Buy
236
+215
+1,024% +$11.6K ﹤0.01% 852
2021
Q4
$1K Sell
21
-87
-81% -$5.32K ﹤0.01% 2262
2021
Q3
$7K Buy
108
+87
+414% +$5.94K ﹤0.01% 1397
2021
Q2
$1K Sell
21
-32
-60% -$1.89K ﹤0.01% 2272
2021
Q1
$3K Buy
53
+32
+152% +$1.74K ﹤0.01% 1617
2020
Q4
$1K Hold
21
﹤0.01% 1488
2020
Q3
$1K Hold
21
﹤0.01% 1473
2020
Q2
$1K Hold
21
﹤0.01% 1395
2020
Q1
$1K Hold
21
﹤0.01% 1388
2019
Q4
$1K Buy
+21
New +$501 ﹤0.01% 1471

Other funds holding AXNX

TCI Wealth Advisors's AXNX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 88 shares — an estimated $4.8K sold.

TCI Wealth Advisors first reported a position in AXNX in Q4 2019 and held it in 14 quarters. The position peaked at $15K in Q1 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 88 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $4.8K.
  • TCI Wealth Advisors first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 14 quarters.
  • TCI Wealth Advisors's Axonics, Inc. Common Stock position peaked at $15K in Q1 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.